Position history for UBS Group AG's holdings in INVESCO BIOTECHNOLOGY
UBS Group AG holds 68,976 shares of PBE (INVESCO BIOTECHNOLOGY), worth $5.5M as of 2026-Q1. The position was increased (+2.4% shares). PBE represents 0.0% of UBS Group AG's portfolio.
Current Value
$5.5M
Current Shares
68,976
Total Value Change
+$539,286
Total Shares Change
-6,968
Other major holders of PBE: MORGAN STANLEY
Increased |
| 68,976 |
+2.4% |
| $5.5M |
| 0.0% |
| $79.79 |
28 |
| 2025-Q4 | Decreased | 67,361 | -6.5% | $5.5M | 0.0% | $82.41 | 0 |
| 2025-Q3 | Decreased | 72,025 | -5.2% | $5M | 0.0% | $68.80 | 0 |
| 2025-Q2 | Increased | 75,983 | +3.8% | $4.9M | 0.0% | $63.84 | 28 |
| 2025-Q1 | Decreased | 73,230 | -3.2% | $4.6M | 0.0% | $63.48 | 0 |
| 2024-Q4 | Decreased | 75,676 | -4.8% | $5M | 0.0% | $65.76 | 0 |
| 2024-Q3 | Increased | 79,462 | +4.6% | $5.5M | 0.0% | $69.05 | 28 |
| 2024-Q2 | Decreased | 75,944 | -12.8% | $4.9M | 0.0% | $64.10 | 0 |